Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels
about
The role of calprotectin in pediatric diseaseBiomarkers of inflammatory bowel disease.The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease: a systematic review and meta-analysis.Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation.Progress in the treatment and outcome of pediatric inflammatory bowel disease patients.Accuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease.Clinical utility of calprotectin and lactoferrin in patients with inflammatory bowel disease: is there something new from the literature?Monitoring of therapy for inflammatory bowel disease.The use of fecal calprotectin as a biomarker in gastrointestinal disease.Fecal biomarkers in the diagnosis and monitoring of Crohn's disease.Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease.Assessment of disease activity in pediatric ulcerative colitis.Fecal calprotectin in inflammatory bowel diseases: update and perspectives.Lessons to be learned from serum biomarkers in psoriasis and IBD - the potential role in SpA.C4B gene influences intestinal microbiota through complement activation in patients with paediatric-onset inflammatory bowel disease.Fecal calprotectin and clinical disease activity in pediatric ulcerative colitis.The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease.Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee.Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease.Semiquantitative fecal calprotectin test in postinfectious and non-postinfectious irritable bowel syndrome: cross-sectional study.
P2860
Q26852795-CF3F49EA-6F97-4A59-A2D3-00BB0B3B0DE5Q33746983-90689CAC-FF1A-451D-9D88-043F275614CDQ34344472-92B2D500-6FD9-4E6D-A815-648FB1C8A284Q35634488-E9664268-9DF3-42CE-8B15-E2800F73E9D8Q36056969-74D007BC-1D6E-49AA-A00A-4F5AFE1682E7Q37372542-DAA860E5-6E09-4094-A0E3-749944CD9F52Q38044762-6F6E0888-A998-4491-BBD8-6ACE58CA9442Q38050877-268F6922-0484-4FEE-A6D9-5DA17B53D3ADQ38171862-864EC4CD-CC90-420D-82DE-2E5116677F57Q38219444-7EFC66E2-BA92-4762-A89C-3D83F31253CCQ38293787-2C7AA18D-42E6-44AA-B885-4A03932BDB2AQ38825374-8D6421D6-B599-457D-8A45-5F849FD31E1EQ38961702-28A3C58F-99E6-4AAC-AB21-A90E0CF0FCA9Q38972679-25555817-FB86-4515-8FF7-5BDFDCB9D0B6Q41356664-70CC03C1-E91E-4F40-8B44-3C2AEF2354B0Q43226736-6D925256-5B4F-4BA2-BF72-1B7DC201E34CQ43590711-D5524801-C3BB-4386-A3A3-64FC4943E2DCQ48076664-4294682C-55A9-4CE8-8C53-1FB224398318Q51526875-04E6A302-4FCD-43B6-A016-28A764DF21C9Q53666863-E2FE69EC-87C5-40FC-AA9C-A16CC180A62D
P2860
Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Infliximab in pediatric inflam ...... ases fecal calprotectin levels
@ast
Infliximab in pediatric inflam ...... ases fecal calprotectin levels
@en
type
label
Infliximab in pediatric inflam ...... ases fecal calprotectin levels
@ast
Infliximab in pediatric inflam ...... ases fecal calprotectin levels
@en
prefLabel
Infliximab in pediatric inflam ...... ases fecal calprotectin levels
@ast
Infliximab in pediatric inflam ...... ases fecal calprotectin levels
@en
P2093
P2860
P356
P1476
Infliximab in pediatric inflam ...... ases fecal calprotectin levels
@en
P2093
Anssi Hämäläinen
Kaija-Leena Kolho
Taina Sipponen
P2860
P304
P356
10.3748/WJG.V17.I47.5166
P407
P577
2011-12-01T00:00:00Z